Related Experiment Video

Updated: Jan 29, 2026

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria
12:57

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria

Published on: September 16, 2013

32.8K

Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria

Richard R Watkins1,2, David Van Duin3

  • 1Division of Infectious Diseases, Cleveland Clinic Akron General, Akron, OH, 44302, USA.

F1000Research
|February 23, 2019
PubMed

Insights

Multidrug-resistant Gram-negative bacteria (MDR-GNB) cause severe pneumonia. New antibiotics are emerging to combat these difficult-to-treat infections, offering hope for improved patient outcomes and reduced healthcare burdens.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Pneumonia is a leading global infection.
  • Multidrug-resistant Gram-negative bacteria (MDR-GNB) significantly increase pneumonia's severity, mortality, and healthcare costs.
  • Antimicrobial resistance poses a growing challenge for MDR-GNB pneumonia treatment.

Purpose of the Study:

  • To review risk factors associated with MDR-GNB pneumonia.
  • To discuss current management strategies for MDR-GNB pneumonia.
  • To highlight novel antimicrobial agents for MDR-GNB.

Main Methods:

  • Literature review of risk factors for MDR-GNB pneumonia.
  • Analysis of current clinical guidelines for MDR-GNB pneumonia management.
  • Survey of recently approved and investigational antibiotics targeting MDR-GNB.

Main Results:

  • Several new antibiotics have recently become available in the US and Europe for MDR-GNB.
  • Additional novel agents are in late-stage development for MDR-GNB.
  • Understanding risk factors and current treatments is crucial for effective management.

Conclusions:

  • The landscape of treating MDR-GNB pneumonia is evolving with new therapeutic options.
  • Continued research and development of antimicrobials are essential to combat resistance.
  • A comprehensive approach including risk factor identification and updated management is vital.
Keywords:
Acinetobacter baumanniiEnterobacteriaceaePseudomonas aeruginosaantibiotics

More Related Videos

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

11.4K
Purification and Visualization of Lipopolysaccharide from Gram-negative Bacteria by Hot Aqueous-phenol Extraction05:31

Purification and Visualization of Lipopolysaccharide from Gram-negative Bacteria by Hot Aqueous-phenol Extraction

Published on: May 28, 2012

36.7K

Related Concept Videos

Current Trends in Nursing I01:28

Current Trends in Nursing I

Current trends in nursing include:
5.5K
Current Trends in Nursing II01:30

Current Trends in Nursing II

Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
3.5K
Gram-negative Bacterial Protein Secretion Systems01:17

Gram-negative Bacterial Protein Secretion Systems

Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
900
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
871
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.9K